Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LABORATORY CORPORATION OF AMERICA HOLDINGS

(LH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/28/2021 07/29/2021 07/30/2021 08/02/2021 08/03/2021 Date
283.19(c) 294.66(c) 296.15(c) 297.61(c) 297.9253 Last
540 127 1 181 248 645 845 1 063 421 759 949 Volume
+0.02% +4.05% +0.51% +0.49% +0.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 15 003 M - -
Net income 2021 1 915 M - -
Net Debt 2021 3 556 M - -
P/E ratio 2021 15,1x
Yield 2021 -
Sales 2022 14 097 M - -
Net income 2022 1 238 M - -
Net Debt 2022 3 400 M - -
P/E ratio 2022 22,9x
Yield 2022 -
Capitalization 28 779 M 28 779 M -
EV / Sales 2021 2,16x
EV / Sales 2022 2,28x
Nbr of Employees 70 000
Free-Float 99,0%
More Financials
Company
Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which... 
More about the company
Ratings of Laboratory Corporation of America Holdings
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about LABORATORY CORPORATION OF AMERICA HOLDINGS
07/30LABORATORY OF AMERICA : Deutsche Bank Adjusts Laboratory Corp of America Holding..
MT
07/30LABORATORY OF AMERICA : Mizuho Securities Adjusts Price Target on Laboratory Cor..
MT
07/29SECTOR UPDATE : Health Care Stocks Closing Slightly Higher
MT
07/29SECTOR UPDATE : Health Care Stocks Inching Higher This Afternoon
MT
07/29LABORATORY OF AMERICA : Labcorp Announces 2021 Second Quarter Results Company Ra..
PU
07/29LABORATORY OF AMERICA : Posts Increase in Q2 Adjusted Earnings, Revenue; Raises ..
MT
07/29LABCORP : Q2 Earnings Snapshot
AQ
07/29LABCORP : Announces 2021 Second Quarter Results
BU
07/29LABORATORY OF AMERICA : Earnings Flash (LH) LABCORP Reports Q2 Revenue $3.84B, v..
MT
07/29LABORATORY OF AMERICA : Earnings Flash (LH) LABCORP Posts Q2 EPS $6.13, vs. Stre..
MT
07/29Laboratory Corporation of America Holdings Revised Earnings Guidance for the ..
CI
07/29Laboratory Corporation of America Holdings Reports Earnings Results for the S..
CI
07/29LABORATORY CORPORATION OF AMERICA HO : LH) agreed to acquire outreach laboratory..
CI
07/29LABORATORY CORPORATION OF AMERICA HO : LH) acquired remaining unknown stake in O..
CI
07/21Biospectal announced that it has received CHF 4 million in funding from SeedL..
CI
More news
News in other languages on LABORATORY CORPORATION OF AMERICA HOLDINGS
06/07Warnungen vor Aufhebung der englischen Corona-Maßnahmen nehmen zu
2020ROCHE : erhält FDA-Notfallzulassung für Sars-CoV-2-Antikörpertest
2020GENFIT : signe un contrat exclusif de licence avec LabCorp pour un test de la NA..
2019Schnellbahnstrecke zwischen Jerusalem und Tel Aviv eröffnet
2019STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe (actualisé)
More news
Analyst Recommendations on LABORATORY CORPORATION OF AMERICA HOLDINGS
More recommendations
Stock Trading Strategies
LABORATORY CORPORATION OF AMERICA HOLDINGS - 06/30
Close to a key resistance level
BUY
More Stock Trading Analysis
Chart LABORATORY CORPORATION OF AMERICA HOLDINGS
Duration : Period :
Laboratory Corporation of America Holdings Technical Analysis Chart | LH | US50540R4092 | MarketScreener
Technical analysis trends LABORATORY CORPORATION OF AMERICA HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 297,61 $
Average target price 310,14 $
Spread / Average Target 4,21%
EPS Revisions
Managers and Directors
Adam H. Schechter Chairman, President & Chief Executive Officer
Glenn Andrew Eisenberg Chief Financial Officer & Executive Vice President
Lance V. Berberian Chief Information & Technology Officer & EVP
Brian J. Caveney Chief Medical Officer, EVP & President-Diagnostics
Stephen M. Anderson Chief Scientific Officer-Covance & Senior VP